188 related articles for article (PubMed ID: 33054569)
1. Molecular networking based dereplication of AChE inhibitory compounds from the medicinal plant
Abbas-Mohammadi M; Moridi Farimani M; Salehi P; Ebrahimi SN; Sonboli A; Kelso C; Skropeta D
J Biomol Struct Dyn; 2022 Mar; 40(5):1942-1951. PubMed ID: 33054569
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
3. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
Pandey S; Singh BK
Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular modeling studies of modulated benzyloxychalcones as potential acetylcholinesterase inhibitors.
Abdalla Ali A; Mhamad SA; Hasan AH; Ahmad I; Abdullah SA; Jamil S; Patel H; Murugesan S; Jamalis J
J Biomol Struct Dyn; 2024 Apr; 42(7):3604-3615. PubMed ID: 37293930
[TBL] [Abstract][Full Text] [Related]
6. An
Potshangbam AM; Nandeibam A; Amom T; Potshangbam N; Rahaman H; Rathore RS; Singh LR; Khan A
J Biomol Struct Dyn; 2022 Mar; 40(4):1521-1533. PubMed ID: 33021148
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase-inhibitory activity of Iranian plants: Combined HPLC/bioassay-guided fractionation, molecular networking and docking strategies for the dereplication of active compounds.
Abbas-Mohammadi M; Moridi Farimani M; Salehi P; Nejad Ebrahimi S; Sonboli A; Kelso C; Skropeta D
J Pharm Biomed Anal; 2018 Sep; 158():471-479. PubMed ID: 29960238
[TBL] [Abstract][Full Text] [Related]
8. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ
Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156
[TBL] [Abstract][Full Text] [Related]
9. Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors.
Atanasova M; Dimitrov I; Ivanov S; Georgiev B; Berkov S; Zheleva-Dimitrova D; Doytchinova I
Molecules; 2022 May; 27(10):. PubMed ID: 35630613
[TBL] [Abstract][Full Text] [Related]
10. Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease.
Kuppusamy A; Arumugam M; George S
Int J Biol Macromol; 2017 Feb; 95():199-203. PubMed ID: 27871793
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
12. Constituents of Stachys plants as potential dual inhibitors of AChE and NMDAR for the treatment of Alzheimer's disease: a molecular docking and dynamic simulation study.
Touati I; Abdalla M; Ali NH; AlRuwaili R; Alruwaili M; Britel MR; Maurady A
J Biomol Struct Dyn; 2024 Mar; 42(5):2586-2602. PubMed ID: 37325873
[TBL] [Abstract][Full Text] [Related]
13. The impact of some phenolic compounds on serum acetylcholinesterase: kinetic analysis of an enzyme/inhibitor interaction and molecular docking study.
Işık M; Beydemir Ş
J Biomol Struct Dyn; 2021 Oct; 39(17):6515-6523. PubMed ID: 32746727
[TBL] [Abstract][Full Text] [Related]
14. Exploring potential inhibitors of acetylcholinesterase, lactate dehydrogenases, and glutathione reductase from Hagenia abyssinica (Bruce) J.F. Gmel. based on multi-target ultrafiltration-liquid chromatography-mass spectrometry and molecular docking.
Fan M; Guo M; Chen G; Rakotondrabe TF; Muema FW; Hu G
J Ethnopharmacol; 2024 Oct; 332():118356. PubMed ID: 38763372
[TBL] [Abstract][Full Text] [Related]
15. Biocomputational Screening of Natural Compounds against Acetylcholinesterase.
Ahmad SS; Khan MB; Ahmad K; Lim JH; Shaikh S; Lee EJ; Choi I
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946559
[TBL] [Abstract][Full Text] [Related]
16. In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.
Innok W; Hiranrat A; Chana N; Rungrotmongkol T; Kongsune P
J Comput Aided Mol Des; 2021 Mar; 35(3):325-336. PubMed ID: 33439402
[TBL] [Abstract][Full Text] [Related]
17. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
18. Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment.
Farihi A; Bouhrim M; Chigr F; Elbouzidi A; Bencheikh N; Zrouri H; Nasr FA; Parvez MK; Alahdab A; Ahami AOT
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893530
[No Abstract] [Full Text] [Related]
19. Acetylcholinesterase inhibition of Alzheimer's disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition.
Koly HK; Sutradhar K; Rahman MS
J Biomol Struct Dyn; 2023; 41(22):12532-12544. PubMed ID: 36651199
[TBL] [Abstract][Full Text] [Related]
20. A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations.
Azmal M; Hossen MS; Shohan MNH; Taqui R; Malik A; Ghosh A
PLoS One; 2024; 19(6):e0304490. PubMed ID: 38833492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
